| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Lamattina John L is a Director at Immunome Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 8 sells.
Estimated insider holdings value: $9.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 4,179 | $205.45 | $858,575.55 | -6.4% | -5.3% | - | |
| Nov 27, 2024 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 2,406 | $123.65 | $297,501.90 | -7.5% | -3.1% | +65.8% | |
| Nov 16, 2021 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 4,835 | $161.86 | $782,579.08 | -16.0% | -25.6% | -50.7% | |
| May 24, 2021 | IMNM Immunome Inc. | Director | Buy | 5,440 | $18.57 | $101,027.88 | +5.8% | -23.5% | -81.7% | |
| Sep 4, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 3,335 | $254.96 | $850,291.93 | -13.5% | - | - | |
| Jun 4, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 4,000 | $194.51 | $778,038.80 | -16.0% | - | - | |
| Mar 5, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 3,335 | $160.90 | $536,603.83 | -13.7% | - | - | |
| Nov 17, 2017 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 4,000 | $139.79 | $559,160.00 | -16.0% | - | - |